The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bogolepova A.N.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Moskva

Possibilities of neurotrophic therapy in early recovery after stroke

Authors:

Bogolepova A.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8‑2): 84‑89

DOI: 10.17116/jnevro201911908284

Views: 5434

Downloaded: 81

Download PDF (RU)
Contact the author
Table of contents

POSSIBILITIES OF NEUROTROPHIC THERAPY IN EARLY RECOVERY AFTER STROKE
POSSIBILITIES OF NEUROTROPHIC THERAPY IN EARLY RECOVERY AFTER STROKE

To cite this article:

Bogolepova AN. Possibilities of neurotrophic therapy in early recovery after stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8‑2):84‑89. (In Russ.)
https://doi.org/10.17116/jnevro201911908284

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
 
МСФ на ЯМ
Close metadata
Recommended articles:
Brain-derived neurotrophic factor in the acute and early reco­very period of ischemic stroke: the role of nocturnal hypo­xemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):72-78
Indi­cators of cognitive impairment of varying seve­rity in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):14-20
Repeated ischemic stro­kes due to infe­ctious arte­ritis of both inte­rnal caro­tid and basi­lar arte­ries as a complication of sphe­noiditis and otitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):31-37
Cases of successful thro­mbus extraction in ischemic stroke asso­ciated with the new coro­navirus infe­ction COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):38-46
On the issue of opti­mizing protein and energy supply for patients with acute cere­brovascular acci­dent. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):51-55
Place of oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH in the therapy and reha­bilitation of patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):56-63
The randomized double-blind placebo-controlled study of effi­cacy and safety of mexi­dol in the complex therapy of ischemic stroke in the acute period. S.S. Korsakov Journal of Neurology and Psychiatry. 2006;(12-2):47-54
Cognitive impairment in post-traumatic stress diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):69-74
Methods of cost-effectiveness evaluation of endo­vascular patent fora­men ovale closure for seco­ndary prevention of cryptogenic stroke. Russian Journal of Preventive Medi­cine. 2024;(6):105-110
Asse­ssment of vole­mic status in acute period of ischemic stroke. Russian Journal of Anesthesiology and Reanimatology. 2024;(5):64-71

The high prevalence and disability of patients with ischemic stroke make the further development of the rehabilitation system relevant. The implementation of neuroplasticity mechanisms is largely provided by neurotrophic factors. One of the most well-known neurotrophic drugs is cerebrolysin, the efficacy of which in patients with stroke has been confirmed in many clinical studies. A recent meta-analysis included 9 randomized, double-blind, placebo-controlled clinical studies of using cerebrolysin in 1879 patients with hemispheric ischemic stroke, where it was administered at a dose of 30—50 ml for at least 1 week (10—21 days) and therapy was started during 72 hours after stroke. Cerebrolysin has been shown to give patients a 60% chance of better outcomes after a stroke, improves early recovery and increases the likelihood of better recovery.

Keywords:

ischemic stroke
neurotrophic therapy
cerebrolysin
recovery

Authors:

Bogolepova A.N.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Moskva

List of references:

  1. Focal brain damage in adults: spasticity syndrome. Clinical guidelines. Pod. red. Hat’kovoi S.E. M.: MedPress; 2017. (In Russ.)
  2. Ovbiagele B, Kautz S, Feng W, Adkins DL. Poststroke outcomes. Stroke Res Treat. 2014;2014:828435. Bath PMW, Lees KR. Acute stroke. West J Med. 2000;173(3):209-212. https://doi.org/10.1155/2014/828435
  3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics—2014 update: a report from the american heart association. Circulation. 2014;129(3):399-410. https://doi.org/10.1161/01.cir.0000442015.53336.12
  4. Stinear C. Prediction of recovery of motor function after stroke. Lancet Neurol. 2010;9:1228-1232.
  5. Schinwelsk M, Sławek J. Prevalence of spasticity following stroke and its impact on quality of life with emphasis on disability in activities of daily living. Systematic review. Neurol Neurochir. 2010;44:404-411. https://doi.org/10.1016/S0028-3843(14)60300-5
  6. Barbay M, Taillia H, Nédélec-Ciceri C, Bompaire F, Bonnin C, Varvat J, Grangette F, Diouf M, Wiener E, Mas JL, Roussel M, Godefroy O; GRECOG-VASC Study Group. Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit. Stroke. 2018;49(5):1141-1147. https://doi.org/10.1161/STROKEAHA.117.018889
  7. Kovalenko EA, Bogolepova AN. Dynamics of post-stroke cognitive deficit and the main factors that affect it. Pharmateca. Neurology. 2018;5(358):46-52. (In Russ.)
  8. Rohde D, Gaynor E, Large M, Mellon L, Hall P, Brewer L, Bennett K, Williams D, Dolan E, Callaly E, Hickey A. The Impact of Cognitive Impairment on Poststroke Outcomes: A 5-Year Follow-Up. J Geriatr Psychiatry Neurol. 2019:891988719853044. Epub ahead of print. https://doi.org/10.1177/0891988719853044
  9. Sullivan R, Harding K. Do patients with severe poststroke communication difficulties have a higher incidence of falls during inpatient rehabilitation? A retrospective cohort study. Top Stroke Rehabil. 2019;26(4):288-293. https://doi.org/10.1080/10749357.2019.1591689
  10. Belagaje SR. Stroke Rehabilitation. Continuum (Minneap Minn). 2017;23(1, Cerebrovascular Disease):238-253. https://doi.org/10.1212/CON.0000000000000423
  11. Zeiler SR, Hubbard R, Gibson EM, Zheng T, Ng K, O’Brien R, Krakauer JW. Paradoxical motor recovery from a first stroke after induction of a second stroke: reopening a postischemic sensitive period. Neurorehabil Neural Repair. 2016;30:794-800. https://doi.org/10.1177/1545968315624783
  12. Hendricks HT, van Limbeek J, Geurts AC, Zwarts MJ. Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehabil. 2002;83:1629-1637. https://doi.org/10.1053/apmr.2002.35473
  13. Dromerick AW, Edwardson MA, Edwards DF, Giannetti ML, Barth J, Brady KP, Chan E, Tan MT, Tamboli I, Chia R, Orquiza M, Padilla RM, Cheema AK, Mapstone ME, Fiandaca MS, Federoff HJ, Newport EL. Critical periods after stroke study: translating animal stroke recovery experiments into a clinical trial. Front Hum Neurosci. 2015;9:231. https://doi.org/10.3389/fnhum.2015.00231
  14. Ballester BR, Maier M, Duff A, Cameirão M, Bermúdez S, Duarte E, Cuxart A, Rodríguez S, San Segundo Mozo RM, Verschure PFMJ. A critical time window for recovery extends beyond one-year post-stroke. J Neurophysiol. 2019;122(1):350-357. https://doi.org/10.1152/jn.00762.2018
  15. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischemic stroke, update August 2014. Stroke. 2014;45:222-225. https://doi.org/10.1161/STROKEAHA.114.007024
  16. Saver JL, Smith EE, Fonarow GC, Reeves MJ, Zhao X, Olson DM, Schwamm LH; GWTG-Stroke Steering Committee and Investigators. The «golden hour» and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010;41:1431-1439. https://doi.org/10.1161/STROKEAHA.110.583815
  17. Zahuranec DB, Majersik JJ. Percentage of acute stroke patients eligible for endovascular treatment. Neurology. 2012;79(13 suppl 1):22-25. https://doi.org/10.1212/WNL.0b013e31826957cf
  18. Neurology. National leadership. Edited by Gusev E.I., Konovalov A.N., Skvortsova V.I. 2-e izd., pererab. i dop. M.: GEOTAR-Media; 2018. (In Russ.)
  19. Dinoff A, Herrmann N, Swardfager W, Lanctôt KL. The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis. Eur J Neurosci. 2017;46(1):1635-1646. https://doi.org/10.1111/ejn.13603
  20. Alcantara CC, García-Salazar LF, Silva-Couto MA, Santos GL, Reisman DS, Russo TL. Post-stroke BDNF Concentration Changes Following Physical Exercise: A Systematic Review. Front Neurol. 2018;28;9:637. https://doi.org/10.3389/fneur.2018.00637
  21. Hartbauer M, Hutter-Paie B, Windisch M. Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons. J Neural Transm (Vienna, Austria: 1996). 2001;108(5):581-592.
  22. Zhang L, Chopp M, Wang C, Zhang Y, Lu M, Zhang T, Zhang ZG. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke. J Neurol Sci. 2019;398:22-26. https://doi.org/10.1016/j.jns.2019.01.017
  23. Tatebayashi Y. The dentate gyrus neurogenesis: a common therapeutic target for Alzheimer disease and senile depression? Seishin Shinkeigaku Zasshi. 2003;105:398-404.
  24. Xing S, Zhang J, Dang C, Liu G, Zhang Y, Li J, Fan Y, Pei Z, Zeng J. Cerebrolysin reduces amyloid-β deposits, apoptosis and autophagy in the thalamus and improves functional recovery after cortical infarction. J Neurol Sci. 2014;337(1-2):104-111. https://doi.org/10.1016/j.jns.2013.11.028
  25. Catalin B, Rogoveanu OC, Pirici I, Balseanu TA, Stan A, Tudorica V, Balea M, Mindrila I, Albu CV, Mohamed G, Pirici D, Muresanu DF. Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke. CNS Neurol Disord Drug Targets. 2018;17(4):299-308. https://doi.org/10.2174/1871527317666180425124340
  26. Hanson LR, Liu XF, Ross TM, Doppler E, Zimmermann-Meinzingen S, Moessler H, Frey WH. Cerebrolysin reduces infarct volume in a rat model of focal cerebral ischemic damage. Am J Neuroprotec Neuroregen. 2009;1(1):60-66. https://doi.org/10.1166/ajnn.2009.1010
  27. Zhang L, Chopp M, Lu M, Zhang T, Winter S, Doppler E, Meier D, Chao L, Eapen A, Pabla P, Gang Zhang Z. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study. International Journal of Stroke. 2016;11(3):347-55. https://doi.org/10.1177/1747493015625645
  28. Amiri-Nikpour MR, Nazarbaghi S, Ahmadi-Salmasi B, Mokari T, Tahamtan U, Rezaei Y. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke. Neuropsychiatr Dis Treat. 2014;10:2299-2306. https://doi.org/10.2147/NDT.S75304. eCollection 2014
  29. Hong Z, Moessler H, Bornstein N, Brainin M, Heiss WD; CASTA Investigators: A double blind, placebo controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia — CASTA. Int J Stroke. 2009;4:406-412.
  30. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z; Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators: Cerebrolysin in patients with acute ischemic stroke in Asia: Results of a double blind, placebo controlled randomized trial. Stroke. 2012;43:630-636. https://doi.org/10.1161/STROKEAHA.111.628537
  31. Chukanova EI, Gusev EI, Belousov DYu, Repyev AP, Belousov YuB. Results of multicenter randomized controlled clinical-economic study of therapy of acute ischemic stroke with Cerebrolysin. Good Clinical Practice. 2011;3:14-37.(In Russ.)
  32. Chang WH, Park CH, Kim DY, Shin YI, Ko MH, Lee A, Jang SY, Kim YH. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke. BMC Neurol. 2016;16:31. https://doi.org/10.1186/s12883-016-0553-z
  33. Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016;47(1):151-159. https://doi.org/10.1161/STROKEAHA.115.009416
  34. Guekht A, Vester J, Heiss WD, Gusev E, Hoemberg V, Rahlfs VW, Bajenaru O, Popescu BO, Doppler E, Winter S, Moessler H, Muresanu D. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurol Sci. 2017;38(10):1761-1769. https://doi.org/10.1007/s10072-017-3037-z
  35. Uivarosan D, Tit DM, Iovan C, Nistor-Cseppento DC, Endres L, Lazar L, Sava C, Sabau AM, Buhas C, Moleriu LC, Bungau S, Aleya L. Effects of combining modern recovery techniques with neurotrophic medication and standard treatment in stroke patients. Sci Total Environ. 2019;679:80-87. https://doi.org/10.1016/j.scitotenv.2019.05.070
  36. Martinez RM. Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation. J Med Life. 2017;10(3):161-166.
  37. Chemer N, Bilanovskyi V. Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives. Neurol Ther. 2019;8(1):25-27. https://doi.org/10.1007/s40120-019-0128-1
  38. Bornstein NM, Guekht A, Vester J, Heiss WD, Gusev E, Hömberg V, Rahlfs VW, Bajenaru O, Popescu BO, Muresanu D. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci. 2018;39(4):629-640. https://doi.org/10.1007/s10072-017-3214-0
  39. Skvortsova VI, Stakhovskaya LV, Gubskiĭ LV, Shamalov NA, Tikhonova IV, Smychkov AS. A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2004;104(suppl 11):51-55. (In Russ.)
  40. Shamalov NA, Stakhovskaya LV, Burenchev DV, Kichuk IV, Tvorogova TV, Botsina AYu, Smichkov AS, Kerbikov OB, Messler G, Novak F, Skvortsova VI, Odinak MM, Voznyuk IA, Rumyantseva SA, Klocheva EG, Novikova LB, Janiszewski SN, Golokhvastov SJ, Tzigan NV. The effect of cerebrolysin in dosage 50 ml on the volume of lesion in ischemic stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2010;110(12 Pt 2):34-37. (In Russ.)
  41. Guekht A, Heiss D, Gusev E, Vester J, Doppler E, Muresanu D. Cerebrolysin and recovery after stroke (CARS 2): a randomized, placebo-controlled, double-blind, multicenter clinical study. J Neurol Sci. 2015;357:e103. https://doi.org/10.1016/j.jns.2015.08.336
  42. Lang W, Stadler CH, Poljakovic Z, Fleet D. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Int J Stroke. 2013;8(2):95-104. https://doi.org/10.1111/j.1747-4949.2012.00901.x
  43. Gharagozli K, Harandi AA, Houshmand S, Akbari N, Muresanu DF, Vester J, Winter S, Moessler H. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. J Med Life. 2011;10(3):153-160.
  44. Xue LX, Zhang T, Zhao YW, Geng Z, Chen JJ, Chen H. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: effects on neurological and behavioral outcomes in acute ischemic stroke. Exp Ther Med. 2016;11(5):2015-2020. https://doi.org/10.3892/etm.2016.3139

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.